AbbVie Announces Positive Results from Phase 3 Trial for Parkinson’s Disease Monotherapy
AbbVie has reported positive topline results from its pivotal Phase 3 TEMPO-1 trial evaluating tavapadon as a monotherapy for early-stage
Read more
DISEASES
Novavax Secures EC Approval for Updated 2024-2025 COVID-19 Vaccine
The leading global biotechnology company advancing protein-based vaccines, Novavax, announced that the European Commission has granted Marketing Authorisation for the
Read more
AOP Health’s First-in-class Investigational Cancer Drug Enters Phase 1 Trial
AOP Orphan Pharmaceuticals GmbH (AOP Health), in collaboration with Leukos Biotech, has reached a significant milestone in cancer therapy. The
Read more
AstraZeneca’s FluMist Influenza Vaccine FDA Approved for Self-Administration
In a landmark approval, the U.S. Food and Drug Administration (FDA) has cleared AstraZeneca’s FluMist, the only influenza vaccine that
Read more
Reseacrhers Develop Nanobots for Precision Drug Release in Aneurysm Treatment
In a groundbreaking leap, researchers have engineered microscopic magnetic robots that could transform the treatment of deadly brain bleeds caused
Read more
ipRGCs as Early Biomarkers for Neurodegenerative Disease Detection
Groundbreaking Research Highlights ipRGCs as Promising Biomarkers for Neurodegenerative Diseases A Striatech .pdf Case Study OptoDrum plays a key role
Read more
GSK Announces Positive Phase III Trial Results for Nucala in COPD Patients
GSK has announced promising headline results from its Phase III clinical trial, MATINEE, which evaluated the efficacy of Nucala (mepolizumab)
Read more
Novavax Wins FDA Emergency Approval for 2024-2025 COVID-19 Vaccine Formula
Novavax, a global leader in protein-based vaccines, has announced that its updated COVID-19 vaccine, Adjuvanted (2024-2025 Formula) (NVX-CoV2705), has received
Read more
Neuroprotective Potential of Vitamin C Identified for Glaucoma Treatment
New Research Highlights the Potential of Vitamin C in Protecting Vision for Glaucoma Patients A Striatech .pdf Case Study OptoDrum,
Read more
FDA Approves Pfizer and BioNTech’s Omicron KP.2-adapted COVID-19 Vaccine
Pfizer and BioNTech have announced that the U.S. Food and Drug Administration (FDA) has approved their supplemental Biologics License Application
Read more